Bani Jolly

The paper reprocesses SARS-CoV-2 genomic data to correct systematic errors in phylogenies using a novel assembly tool, resulting in a cleaner global tree of 4.47 million samples.

This study analyzes whole genome sequences of 1029 Indian individuals to characterize blood group antigens and alleles, identifying rare phenotypes and comparing them with global populations.

The paper reports genome sequences of Lumpy Skin Disease Virus from an outbreak in India, finding a distinct lineage with significant genetic variations compared to the reference genome.

The paper identifies a distinct phylogenetic cluster of monkeypox virus genomes, lineage A.2, which differs from the dominant lineage B.1 associated with the 2022 European outbreak.

This study reports HNA allele and genotype frequencies in the Indian population using whole genome sequencing, finding significant differences in HNA5 variant prevalence compared to other global populations.

The paper analyzes genetic variants of human platelet antigens in 1029 Indian genomes to determine allele frequencies and compare them to global populations.

The paper builds a database of SARS-CoV-2 immune escape variants, curating 5258 variants tested against 230 antibodies, plasma, and vaccine breakthroughs.

The paper analyzes SARS-CoV-2 isolates from Kerala, India, identifying 166 unique variants, including 4 novel ones, and reports on their genetic epidemiology and potential impact on diagnostics.

This study evaluates the COVIDSeq protocol for SARS-CoV-2 detection and genetic epidemiology, showing high concordance with RT-PCR and identifying novel variants and lineages.

This study sequenced SARS-CoV-2 genomes from Andhra Pradesh, identifying 564 variants including 15 novel ones and 4 associated with increased infectivity.

The paper investigates the genetic epidemiology of immune escape variants in SARS-CoV-2 genomes globally.

The paper analyzes genomic variants in SARS-CoV-2 isolates from India and their potential impact on molecular diagnostic assays.

The paper analyzes SARS-CoV-2 genomes from India, identifying a distinct phylogenetic cluster (Clade I/A3i) that accounts for 41% of Indian isolates and 3.5% globally.